Loss of the interleukin-6 receptor causes immunodeficiency, atopy, and abnormal inflammatory responses
© 2019 Crown copyright. The government of Australia, Canada, or the UK ("the Crown") owns the copyright interests of authors who are government employees. The Crown Copyright is not transferable..
IL-6 excess is central to the pathogenesis of multiple inflammatory conditions and is targeted in clinical practice by immunotherapy that blocks the IL-6 receptor encoded by IL6R We describe two patients with homozygous mutations in IL6R who presented with recurrent infections, abnormal acute-phase responses, elevated IgE, eczema, and eosinophilia. This study identifies a novel primary immunodeficiency, clarifying the contribution of IL-6 to the phenotype of patients with mutations in IL6ST, STAT3, and ZNF341, genes encoding different components of the IL-6 signaling pathway, and alerts us to the potential toxicity of drugs targeting the IL-6R.
Errataetall: |
CommentIn: J Exp Med. 2019 Sep 2;216(9):1969-1971. - PMID 31235508 |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2019 |
---|---|
Erschienen: |
2019 |
Enthalten in: |
Zur Gesamtaufnahme - volume:216 |
---|---|
Enthalten in: |
The Journal of experimental medicine - 216(2019), 9 vom: 02. Sept., Seite 1986-1998 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Spencer, Sarah [VerfasserIn] |
---|
Links: |
---|
Themen: |
Case Reports |
---|
Anmerkungen: |
Date Completed 10.06.2020 Date Revised 10.02.2024 published: Print-Electronic CommentIn: J Exp Med. 2019 Sep 2;216(9):1969-1971. - PMID 31235508 Citation Status MEDLINE |
---|
doi: |
10.1084/jem.20190344 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM298496569 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM298496569 | ||
003 | DE-627 | ||
005 | 20240210232222.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2019 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1084/jem.20190344 |2 doi | |
028 | 5 | 2 | |a pubmed24n1286.xml |
035 | |a (DE-627)NLM298496569 | ||
035 | |a (NLM)31235509 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Spencer, Sarah |e verfasserin |4 aut | |
245 | 1 | 0 | |a Loss of the interleukin-6 receptor causes immunodeficiency, atopy, and abnormal inflammatory responses |
264 | 1 | |c 2019 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 10.06.2020 | ||
500 | |a Date Revised 10.02.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a CommentIn: J Exp Med. 2019 Sep 2;216(9):1969-1971. - PMID 31235508 | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2019 Crown copyright. The government of Australia, Canada, or the UK ("the Crown") owns the copyright interests of authors who are government employees. The Crown Copyright is not transferable. | ||
520 | |a IL-6 excess is central to the pathogenesis of multiple inflammatory conditions and is targeted in clinical practice by immunotherapy that blocks the IL-6 receptor encoded by IL6R We describe two patients with homozygous mutations in IL6R who presented with recurrent infections, abnormal acute-phase responses, elevated IgE, eczema, and eosinophilia. This study identifies a novel primary immunodeficiency, clarifying the contribution of IL-6 to the phenotype of patients with mutations in IL6ST, STAT3, and ZNF341, genes encoding different components of the IL-6 signaling pathway, and alerts us to the potential toxicity of drugs targeting the IL-6R | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, N.I.H., Intramural | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a Receptors, Interleukin-6 |2 NLM | |
700 | 1 | |a Köstel Bal, Sevgi |e verfasserin |4 aut | |
700 | 1 | |a Egner, William |e verfasserin |4 aut | |
700 | 1 | |a Lango Allen, Hana |e verfasserin |4 aut | |
700 | 1 | |a Raza, Syed I |e verfasserin |4 aut | |
700 | 1 | |a Ma, Chi A |e verfasserin |4 aut | |
700 | 1 | |a Gürel, Meltem |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Yuan |e verfasserin |4 aut | |
700 | 1 | |a Sun, Guangping |e verfasserin |4 aut | |
700 | 1 | |a Sabroe, Ruth A |e verfasserin |4 aut | |
700 | 1 | |a Greene, Daniel |e verfasserin |4 aut | |
700 | 1 | |a Rae, William |e verfasserin |4 aut | |
700 | 1 | |a Shahin, Tala |e verfasserin |4 aut | |
700 | 1 | |a Kania, Katarzyna |e verfasserin |4 aut | |
700 | 1 | |a Ardy, Rico Chandra |e verfasserin |4 aut | |
700 | 1 | |a Thian, Marini |e verfasserin |4 aut | |
700 | 1 | |a Staples, Emily |e verfasserin |4 aut | |
700 | 1 | |a Pecchia-Bekkum, Annika |e verfasserin |4 aut | |
700 | 1 | |a Worrall, William P M |e verfasserin |4 aut | |
700 | 1 | |a Stephens, Jonathan |e verfasserin |4 aut | |
700 | 1 | |a Brown, Matthew |e verfasserin |4 aut | |
700 | 1 | |a Tuna, Salih |e verfasserin |4 aut | |
700 | 1 | |a York, Melanie |e verfasserin |4 aut | |
700 | 1 | |a Shackley, Fiona |e verfasserin |4 aut | |
700 | 1 | |a Kerrin, Diarmuid |e verfasserin |4 aut | |
700 | 1 | |a Sargur, Ravishankar |e verfasserin |4 aut | |
700 | 1 | |a Condliffe, Alison |e verfasserin |4 aut | |
700 | 1 | |a Tipu, Hamid Nawaz |e verfasserin |4 aut | |
700 | 1 | |a Kuehn, Hye Sun |e verfasserin |4 aut | |
700 | 1 | |a Rosenzweig, Sergio D |e verfasserin |4 aut | |
700 | 1 | |a Turro, Ernest |e verfasserin |4 aut | |
700 | 1 | |a Tavaré, Simon |e verfasserin |4 aut | |
700 | 1 | |a Thrasher, Adrian J |e verfasserin |4 aut | |
700 | 1 | |a Jodrell, Duncan Ian |e verfasserin |4 aut | |
700 | 1 | |a Smith, Kenneth G C |e verfasserin |4 aut | |
700 | 1 | |a Boztug, Kaan |e verfasserin |4 aut | |
700 | 1 | |a Milner, Joshua D |e verfasserin |4 aut | |
700 | 1 | |a Thaventhiran, James E D |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The Journal of experimental medicine |d 1896 |g 216(2019), 9 vom: 02. Sept., Seite 1986-1998 |w (DE-627)NLM000005967 |x 1540-9538 |7 nnns |
773 | 1 | 8 | |g volume:216 |g year:2019 |g number:9 |g day:02 |g month:09 |g pages:1986-1998 |
856 | 4 | 0 | |u http://dx.doi.org/10.1084/jem.20190344 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 216 |j 2019 |e 9 |b 02 |c 09 |h 1986-1998 |